HIGHFDA DRUG

AvKare Chlorpromazine Hydrochloride 50 mg Tablets Recalled for Foreign Substance Contamination (2025

AvKare recalled 1,512 cartons of CHLORPROMAZINE HYDROCHLORIDE 50 mg tablets distributed nationwide in the U.S. for the presence of a foreign substance. The recall is active as of Sept. 17, 2025. Consumers and healthcare providers should stop using this product immediately and contact AvKARE or a healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 25, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 25, 2025
Hazard Level
HIGH
Brands
AvKare, CHLORPROMAZINE HYDROCHLORIDE
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
AvKare, CHLORPROMAZINE HYDROCHLORIDE
Product type
Chlorpromazine hydrochloride tablets
Model numbers
Lot # 46824, Lot # 47171, Exp 9/30/25, Exp 12/31/25
UPC codes
50268-162, 50268-163, 50268-164, 50268-165, 50268-166, 50268-162-11, 50268-162-15, 50268-163-11 +7 more
Sizes
50 mg
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 25, 2025

  2. Reported by FDA DRUG

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of a foreign substance.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact AvKARE or your healthcare provider for guidance. Notification method: E-Mail

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used for various psychiatric conditions. The 50 mg tablet is supplied in unit-dose cartons for clinical use.

Why This Is Dangerous

Contamination with foreign substances can cause adverse reactions or require medical evaluation. Consumers should avoid use until guidance is provided by AvKare.

Industry Context

This recall is not part of a broader industry pattern in this dataset.

Real-World Impact

Immediate halt to use is required to prevent potential adverse events. Patients may require clinical guidance and possible product replacement.

Practical Guidance

How to identify if yours is affected

  1. Inspect cartons for NDC 50268-164-15
  2. Verify lot numbers 46824 or 47171
  3. Check expiration dates 9/30/25 or 12/31/25

Where to find product info

NDC on front panel; lot number and expiration date on carton and seal

What timeline to expect

Replacement or refund process not specified; follow manufacturer guidance; anticipated processing timelines typical for drug recalls (weeks to months)

If the manufacturer is unresponsive

  • Document the request
  • Escalate to FDA recall enforcement or your healthcare provider
  • Contact patient safety or hospital pharmacy for guidance

How to prevent similar issues

  • Verify NDC before dispensing
  • Maintain up-to-date supplier recalls
  • Report any adverse events to FDA MedWatch and hospital risk management

Documentation advice

Keep recall notice, purchase records, lot numbers, expiration dates, and all correspondence

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: CHLORPROMAZINE HYDROCHLORIDE tablets, 50 mg, 50 tablets per carton (5x10 unit dose). NDC 50268-164-15. Sold nationwide in the USA. Manufacturer: AvKare, Pulaski, TN 38478. Quantity: 1,512 cartons. Lot numbers/Exp: Lot # 46824; Exp 9/30/25; Lot 47171; Exp 12/31/25. Status: Active recall as of 2025-08-25; Report date 2025-09-17.

Reported Incidents

No injuries or incidents have been reported in the provided recall notice.

Key Facts

  • Active recall as of 2025-09-17
  • USA nationwide distribution

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETS
Injury Types
POISONINGELECTRICALOTHER

Product Details

Model Numbers
Lot # 46824
Lot # 47171
Exp 9/30/25
Exp 12/31/25
UPC Codes
50268-162
50268-163
50268-164
+12 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls